Formation of advanced glycation end products during CAPD

American Journal of Kidney Diseases

Volumn 41, Issue 3 SUPPL. 1, 2003, Pages

  Tauer, Andreas ^b   Zhang, Xiaohong ^b   Schaub, Thomas P ^b   Zimmeck, Thomas ^b   Niwa, Toshimitsu ^b   Passlick Deetjen, Jutta ^b   Pischetsrieder, Monika ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

3 deoxyglucosone (3 DG); Advanced glycation end products (AGEs); Continuous ambulatory peritoneal dialysis (CAPD); Glucose degradation products (GDPs); Imidazolone; N (carboxymethyl) lysine (CML)

Indexed keywords

3 DEOXYGLUCOSONE; 6 N CARBOXYMETHYLLYSINE; ACETALDEHYDE; ADVANCED GLYCATION END PRODUCT; FORMALDEHYDE; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; IMIDAZOLE DERIVATIVE; METHYLGLYOXAL; PERITONEAL DIALYSIS FLUID;

ABSORPTION; BIOSYNTHESIS; BLOOD LEVEL; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAT TREATMENT; HUMAN; IN VITRO STUDY;

EID: 79958048176     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50086     Document Type: Conference Paper

References (19)

1. Zimmeck T, Tauer A, Fünfrocken M, Pischetsrieder M: How to reduce 3-deoxyglucosone and acetaldehyde in peritoneal dialysis fluids. Perit Dial Int 22:350-356, 2002
2. Niwa T, Katsuazaki T, Miyazaki T, et al: Immunochemical detection of imidazolone, a novel advanced glycation endproduct, in kidneys and aortas of diabetic patients. J Clin Invest 99:1272-1280, 1997
3. Nagaraj R, Shamsi F, Huber B, Pischetsrieder M: Immunochemical detection of oxalate monoalkylamide, an ascorbate derived Maillard reaction product in human lens. FEBS Lett 453:327-330, 1999
4. Pischetsrieder M: Chemistry of glucose and biochemical pathways of biological interest. Perit Dial Int 20:S26-S30, 2000 (suppl 2)
5. ε-(carboxymethyl)-lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis. Biochem Biophys Res Commun 280:1408-1414, 2001
6. Tauer A, Schmitt R, Knerr T, et al: Formation of the glucose degradation product 3-deoxyglucosone and other carbonyl compounds in single- and double-chamber bag PD fluids. Perit Dial Int 20:142A, 2000 (abstr)
7. Linden T, Forsbäck G, Deppisch R, Henle T, Wieslander A: 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int 18:290-293, 1998
8. Igaki N, Sakai M, Hata H, Oimomi M, Baba S, Kato H: Effects of 3-deoxyglucosone on the Maillard reaction. Clin Chem 36:631-634, 1990
9. Jörres A, Witowski J, Korybalska K, et al: Effects of glucose degradation products on human peritoneal mesothelial cell (HPMC) proliferation and interleukin-6 production. Perit Dial Int 18:113A, 1998 (abstr)
10. Wieslander A, Linden T: Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 16:S114-S118, 1996 (suppl 1)
11. Honda K, Nitta K, Horita S, et al: Accumultation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultrafiltration. Nephrol Dial Transplant 14:1541-1549, 1999
12. Mahiout A, Ehlerding G, Brunkenhorst R: Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane on continuous ambulant peritoneal dialysis patients. Nephrol Dial Transplant 11:S2-S6, 1996 (suppl 5)
13. Dawnay A, Millar D: The pathogenesis and consequences of AGE formation in uremia and its treatment. Cell Mol Biol (Noisy-le-grand) 44:1081-1094, 1998
14. Lamb E, Cattel W, Dawnay B: In vitro formation af advanced glycation end products in peritoneal dialysis fluid. Kidney Int 47:1768-1774, 1995
15. Millar D, Holmes C, Faict D, Dawnay A: Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation. Adv Perit Dial 14: 191-194, 1998
16. ε- (Carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation endproducts that activate cell signaling pathways and modulate gene expression. J Biol Chem 274: 31740-31749, 1999
17. Hayase F, Konishi Y, Kato H: Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a Maillard reaction intermediate. Biosci Biotechnol Biochem 59:1407-1411, 1995
18. Linden T, Musi B, Jarkelid L, et al: Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: A study of residual fluid and mesothelial cells. Perit Dial Int 21:607-610, 2001
19. Zhang X, Niwa T, Bosselmann P. et al: Imidazolone in serum of CAPD patients treated three months with standard PD fluid (PDF) and three months with the new dual-chambered PDF balance. Perit Dial Int 22:S18A, 2002 (suppl 1; abstr)